SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 160 filers reported holding ITEOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 6.56 and the average weighting 0.5%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$577,000
-35.1%
17,930
-6.1%
0.01%
-52.2%
Q4 2021$889,000
+197.3%
19,100
+72.2%
0.02%
+360.0%
Q3 2021$299,000
-11.0%
11,090
+11.6%
0.01%
-16.7%
Q4 2020$336,000
-0.6%
9,935
-27.5%
0.01%
-40.0%
Q3 2020$338,00013,7040.01%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$52,174,00019.87%
MPM BioImpact LLC 1,745,943$33,260,0007.88%
Boxer Capital, LLC 2,154,058$41,035,0002.31%
TANG CAPITAL MANAGEMENT LLC 937,500$17,859,0002.19%
RA Capital Management 4,417,259$84,149,0001.80%
BVF INC/IL 1,810,835$34,496,0001.42%
Zebra Capital Management LLC 12,271$234,0000.89%
Integral Health Asset Management, LLC 195,000$3,715,0000.72%
Prairiewood Capital, LLC 32,269$615,0000.51%
DAFNA Capital Management LLC 97,560$1,859,0000.50%
View complete list of ITEOS THERAPEUTICS INC shareholders